Axogen, Inc. — Director's Dealing 2022

Jun 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2022-06-01

Reporting Person: THOMAS PAUL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-01	Common Stock	A	3036	—	Acquired	3036	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-01	Restricted Stock Units	$	M	3036	Disposed		Common Stock (3036.0)	Direct
2022-06-01	Stock Option (right to purchase)	$9.29	A	11811	Acquired	2032-06-01	Common Stock (11811.0)	Direct
2022-06-01	Restricted Stock Units	$	A	6459	Acquired		Common Stock (6459.0)	Direct

Footnotes

F1: This reflects the number of restricted stock units that vested on June 1, 2022.

F2: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F3: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date.

F4: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.